Quanterix Corporation Deferred Revenue
Quanterix Corporation (QTRX) had Deferred Revenue of $5.44 million as of 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-03-18
- 2018-12-31: Deferred Revenue, Current $5.44M.
- 2018-09-30: Deferred Revenue, Current $4.75M.
- 2018-06-30: Deferred Revenue, Current $6.14M.
- 2018-03-31: Deferred Revenue, Current $5.84M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-12-31 | $5.44M 10-K · filed 2019-03-18 |
| 2018-09-30 | $4.75M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $6.14M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $5.84M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $4.94M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |